Sphera Funds Management Ltd. Celldex Therapeutics, Inc. Transaction History

Sphera Funds Management Ltd.

  • $363 Million
  • Q2 2025

A detailed history of Sphera Funds Management Ltd. transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 419,540 shares of CLDX stock, worth $11 Million. This represents 2.35% of its overall portfolio holdings.

Number of Shares
419,540
Previous 507,829 17.39%
Holding current value
$11 Million
Previous $9.22 Million 7.38%
% of portfolio
2.35%
Previous 2.43%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$15.13 - $21.65 $1.34 Million - $1.91 Million
-88,289 Reduced 17.39%
419,540 $8.54 Million
Q1 2025

May 15, 2025
BUY
$18.15 - $27.6 $612,126 - $930,837
33,726 Added 7.11%
507,829 $9.22 Million
Q4 2024

Feb 14, 2025
BUY
$23.31 - $32.4 $1.28 Million - $1.78 Million
55,000 Added 13.12%
474,103 $12 Million
Q3 2024

Nov 14, 2024
BUY
$32.06 - $44.56 $3.52 Million - $4.89 Million
109,838 Added 35.52%
419,103 $14.2 Million
Q2 2024

Aug 14, 2024
BUY
$32.76 - $42.56 $1.06 Million - $1.37 Million
32,269 Added 11.65%
309,265 $11.4 Million
Q1 2024

May 15, 2024
SELL
$35.22 - $51.88 $1.36 Million - $2.01 Million
-38,648 Reduced 12.24%
276,996 $11.6 Million
Q4 2023

Feb 14, 2024
BUY
$22.61 - $40.65 $3.07 Million - $5.51 Million
135,644 Added 75.36%
315,644 $12.5 Million
Q3 2023

Nov 14, 2023
BUY
$25.45 - $37.46 $509,000 - $749,200
20,000 Added 12.5%
180,000 $4.95 Million
Q2 2023

Aug 14, 2023
BUY
$30.29 - $38.28 $4.85 Million - $6.12 Million
160,000 New
160,000 $5.43 Million
Q1 2022

May 16, 2022
SELL
$27.64 - $39.32 $4.61 Million - $6.56 Million
-166,766 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$35.68 - $56.27 $1.3 Million - $2.05 Million
36,436 Added 27.96%
166,766 $6.44 Million
Q3 2021

Nov 15, 2021
BUY
$28.95 - $55.99 $3.77 Million - $7.3 Million
130,330 New
130,330 $7.04 Million
Q2 2021

Aug 17, 2021
SELL
$20.71 - $35.37 $4.56 Million - $7.79 Million
-220,320 Closed
0 $0
Q1 2021

May 17, 2021
SELL
$16.19 - $29.91 $6.1 Million - $11.3 Million
-376,878 Reduced 63.11%
220,320 $4.54 Million
Q4 2020

Feb 16, 2021
BUY
$14.99 - $22.75 $3.41 Million - $5.17 Million
227,198 Added 61.4%
597,198 $10.5 Million
Q3 2020

Nov 12, 2020
BUY
$9.65 - $15.19 $3.57 Million - $5.62 Million
370,000 New
370,000 $5.49 Million

Others Institutions Holding CLDX

# of Institutions
199
Shares Held
68.2M
Call Options Held
219K
Put Options Held
238K
View Full List

About Celldex Therapeutics, Inc.

CLDX Quotes by TradingView
  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $1.23B
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track Sphera Funds Management Ltd. Portfolio

Follow Sphera Funds Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email